Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2,842)
- (1)
- (28,531)
- (2)
- (40)
- (56)
- (1)
- (2)
- (148)
- (248)
- (212)
- (28,359)
- (26)
- (2)
- (91)
- (317)
- (4)
- (15)
- (1)
- (12)
- (1)
- (200)
- (9)
- (28,298)
- (76)
- (6)
- (28,376)
Recombinant
- (29,071)
Form
- (25,440)
- (154)
- (49)
- (3,366)
Species
- (52)
- (89)
- (373)
- (16)
- (2)
- (4)
- (3)
- (27,984)
- (3)
Conjugate
- (7)
- (537)
Keyword Search:
Recombinant Antibody
Clear all selections
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
1
–
15
of
19,188
results
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-13 |
| Molecular Weight (g/mol) | 12.3 kDa |
| Gene Symbol | Il13 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MPVPRSVSLP LTLKELIEEL SNITQDQTPL CNGSMVWSVD LAAGGFCVAL DSLTNISNCN AIYRTQRILH GLCNRKAPTT VSSLPDTKIE VAHFITKLLS YTKQLFRHGP F |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Mouse IL-13 |
| Accession Number | P20109 |
| Regulatory Status | RUO |
| Gene Alias | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
| Biological Activity | The ED50 as determined by the dose-dependent proliferation of TF-1 cells was ≤ 4.0 ng/ml, corresponding to a specific activity of ≥ 2.5 x 10^5 units/mg |
| Gene ID (Entrez) | 16163 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD200 |
| Molecular Weight (g/mol) | 48.5 kDa |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | Monomer: QVQVVTQDER EQLYTPASLK CSLQNAQEAL IVTWQKKKAV SPENMVTFSE NHGVVIQPAY KDKINITQLG LQNSTITFWN ITLEDEGCYM CLFNTFGFGK ISGTACLTVY VQPIVSLHYK FSEDHLNITC SATARPAPMV FWKVPRSGIE NSTVTLSHPN GTTSVTSILH IKDPKNQVGK EVICQVLHLG TVTDFKQTVN KGGGPKSCDK THTCPPCPAP ELLGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSRDELTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK |
| Expression System | CHO cells |
| For Use With (Application) | Functional Assay |
| Name | Human CD200 Fc |
| Accession Number | P41217 |
| Regulatory Status | RUO |
| Gene Alias | antigen identified by monoclonal antibody MRC OX-2; CD200; Cd200 antigen; Cd200 molecule; cell surface protein (thymocyte antigen identified by monoclonal antibody MRC-O x 2); Cspmo2; hypothetical protein LOC534910; MO x 1; MO x 2; MRC; MRC OX-2 antigen; MRCO x 2; My033; O x 2; OX-2; OX-2 membrane glycoprotein |
| Format | Lyophilized |
| Biological Activity | Determined by its ability to bind Human CD200 R1 Fc in a functional ELISA. |
| Gene ID (Entrez) | 4345 |
| Formulation | protein with no preservative |
| Protein Tag | Fc-tag |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-12 p70 |
| Molecular Weight (g/mol) | 75 kDa |
| Gene Symbol | IL12A, Il12b |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | p35 subunit: RNLPVATPDP GMFPCLHHSQ NLLRAVSNML QKARQTLEFY PCTSEEIDHE DITKDKTSTV EACLPLELTK NESCLNSRET SFITNGSCLA SRKTSFMMAL CLSSIYEDLK MYQVEFKTMN AKLLMDPKRQ IFLDQNMLAV IDELMQALNF NSETVPQKSS LEEPDFYKTK IKLCILLHAF RIRAVTIDRV MSYLNAS p40 subunit: IWELKKDVYV VELDWYPDAP GEMVVLTCDT PEEDGITWTL DQSSEVLGSG KTLTIQVKEF GDAGQYTCHK GGEVLSHSLL LLHKKEDGIW STDILKDQKE PKNKTFLRCE AKNYSGRFTC WWLTTISTDL TFSVKSSRGS SDPQGVTCGA ATLSAERVRG DNKEYEYSVE CQEDSACPAA EESLPIEVMV DAVHKLKYEN YTSSFFIRDI IKPDPPKNLQ LKPLKNSRQV EVSWEYPDTW STPHSYFSLT FCVQVQGKSK REKKDRVFTD KTSATVICRK NASISVRAQD RYYSSSWSEW ASVPCS |
| Expression System | HEK293 cells |
| For Use With (Application) | Functional Assay |
| Source | HEK293 cells |
| Name | Human IL-12 p70 |
| Accession Number | P29459, P29460 |
| Regulatory Status | RUO |
| Gene Alias | 20C2; CLMF; CLMF p35; CLMF p40; CLMF2; cytokine; cytotoxic lymphocyte maturation factor 1, p35; cytotoxic lymphocyte maturation factor 35 kDa subunit; Cytotoxic lymphocyte maturation factor 40 kDa subunit; il 12; IL 12p70; Il12; IL-12; Il-12 p35; IL-12 p75; IL-12 subunit p35; IL-12 subunit p40; IL-12, subunit p35; IL12, subunit p40; Il-12; cytokine; IL12A; IL-12 A; IL12A/B; IL12AB; IL12B; Il-12 b; IL12P35; IL-12p35; Il12p40; Il-12p40; IL35 subunit; ILN; IMD28; IMD29; Interleukin; interleukin 12 35 kDa subunit; interleukin 12 35 kDa subunit; interleukin 12 40 kDa subunit; interleukin 12 40 kDa subunit; interleukin 12 p35 subunit; interleukin 12 p40 subunit precursor; interleukin 12 polypeptide 35; interleukin 12, p35; interleukin 12, p40; interleukin 12 A; interleukin 12 A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); interleukin 12 B; interleukin 12 B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); interleukin 12p35 subunit precursor; interleukin-12 alpha chain; interleukin-12 alpha p40 subunit; interleukin-12 beta chain; interleukin-12 beta p35 subunit; interleukin-12 p35 subunit; interleukin-12 p35 subunit precursor; interleukin-12 p40; interleukin-12 p40 subunit; interleukin-12 p40 subunit precursor; Interleukin-12 p70; interleukin-12 subunit alpha; Interleukin-12 subunit beta; interleukin-23 p40 subunit; Ll12a; MGC151228; MGC151232; natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35; natural killer cell stimulatory factor, 40 kD subunit; NF cell stimulatory factor chain 1; NFSK; NK cell stimulatory factor chain 1; NK cell stimulatory factor chain 2; NKSF; NKSF1; NKSF2; P35; p40 |
| Biological Activity | Determined by its ability to increase IFN-gamma production by anti-TCR mAb-stimulated PBMCs. |
| Gene ID (Entrez) | 3592, 3593 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-13 |
| Molecular Weight (g/mol) | 12.6 kDa |
| Gene Symbol | Il13 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MSPGPVPPST ALRELIEELV NITQNQKAPL CNGSMVWSIN LTAGMYCAAL ESLINVSGCS AIEKTQRMLS GFCPHKVSAG QFSSLHVRDT KIEVAQFVKD LLLHLKKLFR EGRFN |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IL-13 |
| Accession Number | P35225 |
| Regulatory Status | RUO |
| Gene Alias | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
| Biological Activity | The ED50 as determined by the dose-dependent proliferation of TF-1 cells was ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 3596 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
enQuireBio™ Recombinant Human TGFB1-induced anti-apoptotic factor 1 Protein
A DNA sequence encoding the Homo sapiens (Human) TGFB1-induced anti-apoptotic factor 1, was expressed in the hosts and tags indicated.
| Buffer | Tris-based buffer, 50% glycerol |
|---|---|
| Purity or Quality Grade | Greater than 80% as determined by SDS-PAGE. |
| Gene Symbol | TIAF1 |
| Endotoxin Concentration | Not determined. |
| Sequence | MSSPSSPFRE QSFLCAAGDA GEESRVQVLK NEVRRGSPVL LGWVEQAYAD KCVCGPSAPP APTPPSLSQR VMCNDLFKVN PFQLQQFRAD PSTASLLLCP GGLDHKLNLR GKAWG |
| Name | TGFB1-induced anti-apoptotic factor 1 Protein |
| Accession Number | NP_004731.2 |
| Regulatory Status | Research Use Only |
| Product Type | Recombinant Protein |
| Protein Length | Full Length |
| Gene ID (Entrez) | 9220 |
| Cross Reactivity | Human |
| Protein Tag | GST |
| Species | E. coli |
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-13 |
| Molecular Weight (g/mol) | 12.5 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of human TF-1 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IL-13 |
| Purification Method | Purified |
| Gene Alias | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of human TF-1 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Immunology, Respiratory Research, Inflammation, Signal Transduction |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
| Gene Symbol | Il13 |
| Sequence | MSPGPVPPST ALRELIEELV NITQNQKAPL CNGSMVWSIN LTAGMYCAAL ESLINVSGCS AIEKTQRMLS GFCPHKVSAG QFSSLHVRDT KIEVAQFVKD LLLHLKKLFR EGRFN |
| Storage Requirements | -20°C |
| Protein Subtype | Interleukins |
| Accession Number | P35225 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 3596 |
| Product Line | Gibco |
| Purity or Quality Grade | 85% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Liquid |
| Common Name | DYRK1A |
| Molecular Weight (g/mol) | 113 kDa |
| Sequence | Full length |
| Concentration | See Label |
| Expression System | Insect cells |
| For Use With (Application) | Kinase Assay |
| Name | Human DYRK1A, GST Tag |
| Accession Number | Q13627 |
| Gene ID (Entrez) | 1859 |
| Protein Tag | GST-tag |
| Species | Human |
| Recombinant | Recombinant |
| Regulatory Status | RUO |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Recombinant | Recombinant |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | ≥95% as determined by SDS-PAGE. ≥95% as determined by SEC-HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-13 |
| Molecular Weight (g/mol) | 12.35 kDa |
| Gene Symbol | Il13 |
| Activity | Measured in a cell proliferation assay using TF1 human erythroleukemic cells (Kitamura, T. et al. 1989, J. Cell Physiol. 140:323.). The ED50 for this effect is typically 0.5-3 ng/mL. |
| Endotoxin Concentration | <0.01 EU/μg |
| Sequence | Human IL13, amino acids Met1-Asn132 (Accession # AAK53823.1) |
| Concentration | 0.25 mg/mL |
| Expression System | CHO cells |
| For Use With (Application) | Control,Bioactivity |
| Name | Human IL-13 |
| Accession Number | P35225 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Measured in a cell proliferation assay using TF1 human erythroleukemic cells (Kitamura, T. et al. 1989, J. Cell Physiol. 140:323.). The ED50 for this effect is typically 0.5-3 ng/mL |
| Gene ID (Entrez) | 3596 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Recombinant | Recombinant |
| Accession Number | P01375 |
|---|---|
| Regulatory Status | RUO |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 7124 |
| Gene Symbol | Tnf |
| Source | E. coli |
| Recombinant | Recombinant |
| Name | Human TNF-alpha |
| Content And Storage | Includes 1 vial of lyophilized protein. Store at -20 °C. |
|---|---|
| Purity or Quality Grade | ≥90 % as determined by SDS-PAGE. ≥90 % as determined by SEC-HPLC. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Her-2 (ErbB2) |
| Molecular Weight (g/mol) | 96.1 kDa |
| Gene Symbol | ERBB2 |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human ErbB2, amino acids Met1-Thr652 (Accession # NP_004439.2) with a C-terminal Fc-tag |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,Binding Assay,Bioactivity,Western Blot |
| Source | HEK293 cells |
| Name | Human ErbB2 Fc Chimera |
| Accession Number | P04626 |
| Regulatory Status | RUO |
| Gene Alias | avian erythroblastosis oncogene B 2; Avian erythroblastosis viral (v-erb-B2) oncogene homologue 2 (neuro/glioblastoma derived oncogene homolog); CD antigen CD340; CD340; c-erb B2/neu protein; c-erbB2; C-erbB-2; c-neu; epidermal growth factor receptor-related protein; erbb 2; ERBB2; erb-b2; Erbb-2; ErbB2 (pTyr1139); ErbB2 (pY1139); ErbB2 phospho Y1139; erb-b2 receptor tyrosine kinase 2; her 2; HER2; HER-2; HER-2/neu; herstatin; human epidermal growth factor receptor 2; Kiaa3023; metas; Metastatic lymph node gene 19 protein; mKIAA3023; MLN 19; MLN19; NEU; Neu oncogene; NEU proto-oncogene; neuro/glioblastoma derived oncogene homolog; neuroblastoma/glioblastoma derived oncogene homolog; NGL; p185erbB2; p185neu; phospho ErbB2; proto-oncogene c-ErbB-2; Proto-oncogene Neu; receptor tyrosine-protein kinase erbB-2; TKR1; Tyrosine kinase-type cell surface receptor HER2; v-erb-b2 avian erythroblastic leukemia viral oncogene 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
| Biological Activity | 1. Immobilized Human ErbB2 Fc Chimera Recombinant Protein (at 2 μg/mL (100 μL/well) can bind Anti-Erbb2 Antibody (Trastuzumab), the EC50 is 16-80 ng/mL 2. Measured by its ability to block anti-ErbB2 mediated inhibition of BT474 human breast ductal carcinoma cell proliferation. The ED50 for this effect is 0.5-3 μg/mL in the presence of 0.6 μg/mL Anti-ErbB2/Her2 Monoclonal Antibody.) |
| Gene ID (Entrez) | 2064 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | Fc-tag |
| Recombinant | Recombinant |
| Conjugate | Unconjugated |
|---|---|
| Form | Liquid |
| pH Range | 7.5 |
| Common Name | MST1 (STK4) |
| Molecular Weight (g/mol) | 83.1 kDa |
| KinaseFamily | STE20 Kinase Family |
| Expression System | Insect cells |
| For Use With (Application) | Kinase Assay |
| Name | Human STK4 (MST1), GST Tag |
| Purification Method | Purified |
| Gene Alias | AI447339; AU020804; EC 2.7.11.1; Kas-2; kinase MST1; kinase responsive to stress 2; KRS2; Mammalian STE20-like protein kinase 1; mammalian sterile 20-like 1; MST1; MST-1; MST1/C; MST1/N; serine/threonine kinase 4; serine/threonine-protein kinase 4; Serine/threonine-protein kinase 4 18kDa subunit; Serine/threonine-protein kinase 4 37kDa subunit; Serine/threonine-protein kinase Krs-2; STE20-like kinase MST1; sterile 20-like kinase 1; STK4; TIIAC; Yeast Sps1/Ste20-related kinase 3; Ysk3 |
| Protein Form | Recombinant, Full Length |
| Formulation | 50mM tris with 2mM DTT, 50% glycerol, 150mM NaCl, 0.5mM EDTA, 0.02% Triton X-100 and no preservative; pH 7.5 |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Dry Ice |
| Gene Symbol | Stk4 |
| Sequence | Full length |
| Storage Requirements | -80°C, Avoid Freeze/Thaw Cycles |
| Concentration | See Label |
| Protein Subtype | Serine/Threonine Kinases |
| Accession Number | Q13043 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 6789 |
| Protein Tag | GST-tag |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | >97% as determined by SDS-PAGE. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD38 |
| Molecular Weight (g/mol) | 43-45 kDa |
| Gene Symbol | CD38 |
| Activity | 1. Measured by its ability to convert the substrate nicotinamide guanine dinucleotide (NGD+) to cyclic GDPribose.The specific activity is > 2,500 pmoles/min/ μg. 2. Measured by its binding ability in a functional ELISA. Immobilized Human CD38 His at 2 μg/ml (100 μL/well) can bind Mouse Anti-CD38 Antibody, the EC50 of Mouse Anti-CD38 Antibody is 30-120 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human CD38, amino acids Val43-Ile300 (Accession # NP_001766.2) with a C-terminal His-tag |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | Human CD38 His-tag |
| Accession Number | P28907 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | 2'-phospho-ADP-ribosyl cyclase; 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase; 2'-phospho-cyclic-ADP-ribose transferase; ADPRC 1; ADPRC1; ADP-ribosyl cyclase 1; ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1; Cd38; CD38 antigen; CD38 antigen (ADP-ribosyl cyclase / cyclic ADP-ribose hydrolase); CD38 antigen (p45); CD38 antigen p45; CD38 molecule; CD38H; Cd38-rs1; cluster of differentiation 38; cyclic ADP-ribose hydrolase 1; ecto-nicotinamide adenine dinucleotide glycohydrolase; I-19; NAD(+) nucleosidase; NAD+ nucleosidase; NIM-R5 antigen; T10 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | 1. Measured by its ability to convert the substrate nicotinamide guanine dinucleotide (NGD+) to cyclic GDPribose.The specific activity is > 2,500 pmoles/min/ μg. 2. Measured by its binding ability in a functional ELISA. Immobilized Human CD38 His (at 2 μg/ml (100 μL/well) can bind Mouse Anti-CD38 Antibody, the EC50 of Mouse Anti-CD38 Antibody is 30-120 ng/mL) |
| Gene ID (Entrez) | 952 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
| Purity or Quality Grade | 95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Liquid |
| Common Name | JAK2 |
| Molecular Weight (g/mol) | 66.6 kDa |
| Concentration | See Label |
| Expression System | Insect cells |
| For Use With (Application) | Kinase Assay |
| Name | Human JAK2, GST Tag |
| Accession Number | O60674 |
| Gene Alias | EC 2.7.10.2; Fd17; JAK 2; JAK2; JAK-2; Janus kinase 2; Janus kinase 2 (a protein tyrosine kinase); JTK 10; JTK10; kinase Jak2; THCYT3; Tyrosine-protein kinase JAK2 |
| Gene ID (Entrez) | 3717 |
| Protein Tag | GST-tag |
| Species | Human |
| Recombinant | Recombinant |
| Conjugate | Unconjugated |
|---|---|
| Form | Liquid |
| Sequence | Full length |
| Concentration | See Label |
| For Use With (Application) | Kinase Assay |
| Species | Human |
| Recombinant | Recombinant |